SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication covering the largest independent prospective prenatal study comparing optical genome ...

Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Europe Microarray Analysis Market: Focus on Product, Type, Application, End User, and Country Level Analysis - Analysis and Forecast, 2023-2033" report ...

Spotfire, Inc. has announced DecisionSite® for Microarray Analysis (DSMA), which gives drug makers a competitive advantage in quickly and accurately identifying potential drug targets. DSMA, available ...

A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

For biologists, DNA microarrays present at once unprecedented opportunities and monumental challenges. In the opportunities column, microarrays produce genome-wide gene expression snapshots, ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

The global peptide microarray market share analysis is on a steady growth trajectory, projected to reach USD 903.8 million by 2025, with a compound annual growth rate (CAGR) of 3.8%. By 2035, the ...